TCDA
Exchange: NASDAQSector: HealthcareIndustry: Drug Manufacturers - Specialty & Generic
Did you know?
Capital expenditures decreased by 94% from FY20 to FY21.
Current Price
—
Profile
Valuation (TTM)
Market Cap—
P/E—
EV—
P/B—
Shares Out—
P/Sales—
Revenue—
EV/EBITDA—
TCDA (TCDA) — Earnings Call Transcripts
No transcripts available yet
No earnings call transcripts are available for TCDA yet. Check back after the next earnings report.
← Back to TCDA overview